GBI Biomanufacturing Welcomes Sven Lee to Board of Directors
Slice of Manufacturing Team
03/17/2025
Key Highlights:
- GBI Biomanufacturing (GBI) appoints Sven Lee to its board of directors.
- Sven brings decades of experience in the biologics CDMO sector, including strategic growth, commercialization, and innovation.
- Previously held leadership roles at Abzena, Catalent, and Biocina.
- GBI strengthens its global presence and service excellence with this key leadership addition.
- Continued commitment to innovative, high-quality biomanufacturing solutions.
Source: PR Newswire
Quotes
“ "We are thrilled to welcome Sven to our board. He brings a wealth of industry knowledge, insights, and a strong reputation that will strengthen our commitment to serve and deliver high-quality development and manufacturing solutions to our clients worldwide." ”
Karl Pinto, Chairman & CEO at GBI
Why This Matters:
Sven Lee’s addition to GBI Biomanufacturing’s board marks a strategic move to further enhance the company’s leadership in the biologics CDMO industry. With over three decades of experience, GBI has solidified itself as a trusted manufacturing partner for complex biologics. Sven’s expertise in commercialization, licensing, and strategic growth will be instrumental in expanding GBI’s global reach and maintaining its reputation for excellence in biopharmaceutical manufacturing.
